Kringle Pharma, Inc.

2026/08/25 Updated
Market Cap: $21.9M (¥3.5B)
Stock Price: $2.71 (¥431)
Exchange Rate: 1 USD = ¥159.24

Investigation Completion of the Protocol in the Phase III Add-On Trial of Hepatocyte Growth Factor for Acute Spinal Cord Injury

Importance:
Page Updated: July 3, 2026
IR Disclosure Date: July 3, 2026
その他

G-クリングル

Company overview · Stock price · Financial data · All IR

View company page →